Abstract
The cell cycle inhibitor p15INK4B is frequently inactivated by homozygous deletions together with p16INK4a/p14ARF in many tumour types. Although it is now well established that p16INK4a and p14ARF act as tumour suppressor genes, the role of p15INK4b remains to be well defined. In order to explore the possibility of a selective deregulation of p15INK4b in human lung carcinogenesis, we studied p15INK4b status in neuroendocrine (NE) lung tumours where homozygous deletions of the p16INK4a/p14ARF locus are rarely observed. Expressions of p15 and p15.5 protein isoforms were analysed in a series of eight control normal lung, 12 tumour-associated normal lung, five low grade and 15 high grade neuroendocrine (NE) lung tumours and relationship with a specific p15INK4b methylation status was studied. Using Western blot analysis, we showed that p15 and p15.5 isoforms displayed a high heterogeneous pattern of expression in both normal and tumour tissues. P15 and p15.5 expressions were correlated in control normal lung (P<0.04) whereas they were not in tumours and associated normal lung. The level of p15.5 was significantly higher in associated normal lung and in tumours (P<0.02 respectively), specially in low grade tumours (P<0.01), than in control normal lung. Furthermore, p15.5 expression was more variable in tumours than in normal lung (P<0.01) and in low grade than in high grade NE lung tumours (P<0.02). Levels of p15 and p15.5 were distinct (up- or downregulated) from those observed in paired normal lung in 4/12 (33%) and 10/12 (83%) tumours respectively. Aberrant methylation at the 5′ end of p15INK4b gene was observed in 15% of NE lung tumours using PCR-based assay, in a region proximal to the translation start where methylation did not occur in control and associated normal lung. However, no correlation could be assessed with protein status. MSP analysis of CpG islands proximal to the transcription start revealed methylation in all normal and tumour samples. No correlation was found between p15INK4b and p16INK4a or p14ARF status. These data suggest that complex deregulation of p15.5 is implicated in the carcinogenesis of human NE lung tumours independently of p16INK4a and p14ARF status.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aggerholm A, Guldberg P, Hokland M, Hokland P . 1999 Cancer Res. 59: 436–441
Anbazhagan R, Tihan T, Bornman DM, Johnston JC, Saltz JH, Weigering A, Piantadosi S, Gabrielson E . 1999 Cancer Res. 59: 5119–5122
Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D, Sidransky D . 1995 Nature Genet. 11: 210–212
Cameron E, Baylin SB, Herman JG . 1999 Blood 94: 2445–2451
Chin L, Pomerantz J, DePinho RA . 1998 Trends Biochem. Sci. 23: 291–296
Della Valle V, Duro D, Bernard O, Larsen CJ . 1997 Oncogene 15: 2475–2481
Dosaka-Akita H, Cagle PT, Hiroumi H, Fujita M, Yamashita M, Sharma A, Kawakami Y, Benedict WF . 2000 Cancer 88: 550–556
Fuxe J, Raschperger E, Pettersson RF . 2000 Oncogene 19: 1724–1728
Gazzeri S, Gouyer V, Vour'ch C, Brambilla C, Brambilla E . 1998a Oncogene 16: 497–504
Gazzeri S, Della Valle V, Chaussade L, Brambilla C, Larsen CJ, Brambilla E . 1998b Cancer Res. 58: 3926–3931
Glendening JM, Flores JF, Walker GJ, Stone S, Albino AP, Fountain JW . 1995 Cancer Res. 55: 5531–5535
Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA . 1995 Cancer Res. 55: 4531–4535
Gray-Gablin J, Rao S, Keyomarsi K . 1997 Cancer Res. 57: 604–609
Hamada K, Kohno T, Kawanishi M, Ohwada S, Yokota J . 1998 Genes. Chrom. Cancer 22: 232–240
Hannon GJ, Beach D . 1994 Nature (Lond.) 371: 257–261
Harper JW, Elledge SJ . 1996 Curr. Opin. Genet. Dev. 6: 56–64
Herman JG, Jen J, Merlo A, Baylin SB . 1996a Cancer Res. 56: 722–727
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB . 1996b Proc. Natl. Acad. Sci. USA 93: 9821–9826
Herman JG, Civin CI, Issa JPJ, Collector MI, Sharkis SJ, Baylin SB . 1997 Cancer Res. 57: 837–841
Hunter T, Pines J . 1994 Cell 79: 573–582
Iravani M, Daht R, Price C . 1997 Oncogene 15: 2609–2614
Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW, Vogelstein B . 1994 Cancer Res. 54: 6353–6358
Kamb A, Gruis NA, Weaver-feldhaus J, liu Q, Harsham K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH . 1994 Science 264: 436–440
Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, Martin-Caballero J, Flores JM, Cordon-Cardo C, Barnacid M . 2000 EMBO J. 13: 3496–3506
Li JM, Nichols MA, Chandrasekharan S, Xiong Y, Wang XF . 1995 J. Biol. Chem. 270: 26750–26753
Medema RH, Herrera RE, Lam F, Weinberg RA . 1995 Proc. Natl. Acad. Sci. USA 92: 6289–6293
Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D . 1995 Nature. Med. 1: 686–692
Nakagawa K, Conrad N, Williams J . 1995 Oncogene 11: 1843–1851
Okamoto A, Hussain SP, Hagiwara K, Spillare EA, Rusin MR, Demetrick DJ, Serrano M, Hannon GJ, Shiseki M, Zariwala M, Xiong Y, Beach DH, Yokota J, Harris CC . 1995 Cancer Res. 55: 1448–1451
Packenham JP, Taylor JA, White CM, Anna CH, Barrett JC, Devereux TR . 1995 Clin Cancer Res. 1: 687–690
Pollock PM, Pearson JV, Hayward NK . 1996 Genes Chrom. Cancer. 15: 77–88
Rasool O, Heyman M, Brandter LB, Liu Y, Grander D, Soderhall S, Einhorn S . 1995 Blood 85: 3431–3436
Reynisdottir I, Polyak K, Iavarone A, Massgue J . 1995 Genes Dev. 9: 1831–1845
Rusin MR, Okamoto A, Chorazy M, Czyzewski K, Harasim J, Spillare EA, Hagiwara K, Perwez Hussain S, Xiong Y, Demetrick DJ, Harris CC . 1996 Int. J. Cancer. 65: 734–739
Sangfelt O, Erickso S, Einhorn S, Grander D . 1997 Oncogene. 14: 415–423
Sharpless NE, DePinho RA . 1999 Curr. Opin. Genet. Dev. 9: 22–30
Sherr CJ . 1996 Science. 274: 1672–1677
Sherr CJ, Robert JM . 1995 Genes Dev. 13: 1501–1512
Sherr CJ . 1998 Genes Dev. 12: 2984–2991
Stone S, Dayananth P, Jiang P, Weaver-Geldhous JM, Tavtigian SV, Cannon-Albright L, Kamb A . 1995 Oncogene 11: 987–991
Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E . 1999 EMBO J. 18: 4280–4291
Tsubari M, Tiihonen E, Laiho M . 1997 Cancer Res. 57: 2966–2973
Washimi O, Nagatake M, Osada H . 1995 Cancer Res. 55: 514–517
Xiao S, Li D, Corson JM, Vijg J, Fletcher JA . 1995 Cancer Res. 55: 2968–2971
Yuan J, Knorr J, Altmannsberger M, Goeckenjan G, Ahr A, Scharl A, Strebhardt K . 1999 J. Pathol. 189: 358–362
Acknowledgements
We thank C Oddou and P Perron for technical assistance. This work was supported by grants from the Association pour la Recherche sur le Cancer, from the Comité Départemental de la Ligue contre le Cancer de l'Isère et de la Vienne and from the Groupement des Entreprises Françaises dans la lutte contre le Cancer. L Chaussade held a fellowship from the Ministère de la Recherche et de la Technologie and B Eymin was supported by INSERM (Poste d'accueil).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chaussade, L., Eymin, B., Brambilla, E. et al. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15INK4b methylation status. Oncogene 20, 6587–6596 (2001). https://doi.org/10.1038/sj.onc.1204798
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204798
Keywords
This article is cited by
-
Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?
Endocrine Pathology (2021)
-
Induction of p19INK4d in response to ultraviolet light improves DNA repair and confers resistance to apoptosis in neuroblastoma cells
Oncogene (2005)
-
Genetic and Molecular Coordinates of Neuroendocrine Lung Tumors, with Emphasis on Small-cell Lung Carcinomas
Molecular Medicine (2002)